2014 Q2 Form 10-Q Financial Statement
#000119312514298602 Filed on August 07, 2014
Income Statement
Concept | 2014 Q2 | 2013 Q2 |
---|---|---|
Revenue | $736.0K | $4.759M |
YoY Change | -84.53% | 43.82% |
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $2.950M | $1.720M |
YoY Change | 71.51% | 75.51% |
% of Gross Profit | ||
Research & Development | $10.80M | $7.722M |
YoY Change | 39.8% | 58.14% |
% of Gross Profit | ||
Depreciation & Amortization | $350.0K | $340.0K |
YoY Change | 2.94% | 36.0% |
% of Gross Profit | ||
Operating Expenses | $13.75M | $9.445M |
YoY Change | 45.57% | 60.99% |
Operating Profit | -$13.01M | -$4.686M |
YoY Change | 177.7% | 83.19% |
Interest Expense | $10.00K | $18.00K |
YoY Change | -44.44% | -80.0% |
% of Operating Profit | ||
Other Income/Expense, Net | ||
YoY Change | ||
Pretax Income | -$11.97M | -$7.338M |
YoY Change | 63.16% | 179.97% |
Income Tax | $0.00 | $10.00K |
% Of Pretax Income | ||
Net Earnings | -$11.97M | -$7.348M |
YoY Change | 62.94% | 182.72% |
Net Earnings / Revenue | -1626.77% | -154.4% |
Basic Earnings Per Share | -$0.28 | -$0.20 |
Diluted Earnings Per Share | -$0.29 | -$0.20 |
COMMON SHARES | ||
Basic Shares Outstanding | 43.36M shares | 35.99M shares |
Diluted Shares Outstanding | 44.80M shares | 35.99M shares |
Balance Sheet
Concept | 2014 Q2 | 2013 Q2 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $103.5M | $82.70M |
YoY Change | 25.15% | 206.3% |
Cash & Equivalents | $10.02M | $19.17M |
Short-Term Investments | $93.50M | $63.50M |
Other Short-Term Assets | $4.400M | $1.600M |
YoY Change | 175.0% | 166.67% |
Inventory | ||
Prepaid Expenses | ||
Receivables | $2.500M | |
Other Receivables | $0.00 | |
Total Short-Term Assets | $107.9M | $86.87M |
YoY Change | 24.19% | 214.76% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $3.948M | $4.011M |
YoY Change | -1.57% | 17.97% |
Goodwill | ||
YoY Change | ||
Intangibles | $1.112M | $1.229M |
YoY Change | -9.52% | |
Long-Term Investments | ||
YoY Change | ||
Other Assets | $977.0K | $404.0K |
YoY Change | 141.83% | -63.27% |
Total Long-Term Assets | $6.037M | $5.644M |
YoY Change | 6.96% | 0.79% |
TOTAL ASSETS | ||
Total Short-Term Assets | $107.9M | $86.87M |
Total Long-Term Assets | $6.037M | $5.644M |
Total Assets | $113.9M | $92.52M |
YoY Change | 23.14% | 178.67% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $3.018M | $1.028M |
YoY Change | 193.58% | 28.5% |
Accrued Expenses | $4.432M | $2.081M |
YoY Change | 112.97% | -36.94% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $11.27M | $19.01M |
YoY Change | -40.72% | -15.53% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $12.50M | $14.60M |
YoY Change | -14.38% | 3550.0% |
Other Long-Term Liabilities | $1.260M | $1.765M |
YoY Change | -28.61% | -86.93% |
Total Long-Term Liabilities | $1.260M | $1.765M |
YoY Change | -28.61% | -87.3% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $11.27M | $19.01M |
Total Long-Term Liabilities | $1.260M | $1.765M |
Total Liabilities | $31.84M | $43.20M |
YoY Change | -26.29% | 18.35% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$103.8M | -$75.00M |
YoY Change | 38.41% | |
Common Stock | $43.00K | $36.00K |
YoY Change | 19.44% | |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $82.08M | $49.32M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $113.9M | $92.52M |
YoY Change | 23.14% | 178.67% |
Cashflow Statement
Concept | 2014 Q2 | 2013 Q2 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$11.97M | -$7.348M |
YoY Change | 62.94% | 182.72% |
Depreciation, Depletion And Amortization | $350.0K | $340.0K |
YoY Change | 2.94% | 36.0% |
Cash From Operating Activities | -$10.02M | -$7.430M |
YoY Change | 34.86% | 59.1% |
INVESTING ACTIVITIES | ||
Capital Expenditures | -$650.0K | -$190.0K |
YoY Change | 242.11% | -50.0% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $12.20M | $8.910M |
YoY Change | 36.92% | 8810.0% |
Cash From Investing Activities | $11.53M | $8.720M |
YoY Change | 32.22% | -3214.29% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 30.00K | 60.00K |
YoY Change | -50.0% | -127.27% |
NET CHANGE | ||
Cash From Operating Activities | -10.02M | -7.430M |
Cash From Investing Activities | 11.53M | 8.720M |
Cash From Financing Activities | 30.00K | 60.00K |
Net Change In Cash | 1.540M | 1.350M |
YoY Change | 14.07% | -126.11% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$10.02M | -$7.430M |
Capital Expenditures | -$650.0K | -$190.0K |
Free Cash Flow | -$9.370M | -$7.240M |
YoY Change | 29.42% | 68.76% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2014Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
43392345 | shares |
CY2013Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
19170000 | |
CY2014Q2 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
4.00 | |
CY2014Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
43383863 | shares |
CY2014Q2 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
10002686 | shares |
CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.45 | |
CY2014Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
6387000 | shares |
CY2014Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2014Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2014Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
43383863 | shares |
CY2014Q2 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
6861000 | |
CY2014Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
11267000 | |
CY2014Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-42000 | |
CY2014Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1187000 | |
CY2014Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
185883000 | |
CY2014Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3018000 | |
CY2014Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1260000 | |
CY2014Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
82083000 | |
CY2014Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-103801000 | |
CY2014Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
2630000 | |
CY2014Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
4432000 | |
CY2014Q2 | us-gaap |
Liabilities
Liabilities
|
31838000 | |
CY2014Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
43000 | |
CY2014Q2 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
12450000 | |
CY2014Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
113921000 | |
CY2014Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
977000 | |
CY2014Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
1112000 | |
CY2014Q2 | us-gaap |
Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
|
103091000 | |
CY2014Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3948000 | |
CY2014Q2 | us-gaap |
Assets
Assets
|
113921000 | |
CY2014Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
10024000 | |
CY2014Q2 | us-gaap |
Short Term Investments
ShortTermInvestments
|
93477000 | |
CY2014Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
4383000 | |
CY2014Q2 | us-gaap |
Assets Current
AssetsCurrent
|
107884000 | |
CY2014Q2 | rgls |
Short Term Investments Amortized Cost
ShortTermInvestmentsAmortizedCost
|
93486000 | |
CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
40552000 | |
CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
41787326 | shares |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.69 | |
CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5598000 | shares |
CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
200000000 | shares |
CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
41787326 | shares |
CY2013Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
6500000 | |
CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
10370000 | |
CY2013Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-16000 | |
CY2013Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
1297000 | |
CY2013Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
172518000 | |
CY2013Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1172000 | |
CY2013Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
1459000 | |
CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
93457000 | |
CY2013Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-79087000 | |
CY2013Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
4888000 | |
CY2013Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
3013000 | |
CY2013Q4 | us-gaap |
Liabilities
Liabilities
|
29608000 | |
CY2013Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
42000 | |
CY2013Q4 | us-gaap |
Convertible Debt Fair Value Disclosures
ConvertibleDebtFairValueDisclosures
|
11279000 | |
CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
123065000 | |
CY2013Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
987000 | |
CY2013Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
1128000 | |
CY2013Q4 | us-gaap |
Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
|
113368000 | |
CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3768000 | |
CY2013Q4 | us-gaap |
Assets
Assets
|
123065000 | |
CY2013Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
17807000 | |
CY2013Q4 | us-gaap |
Short Term Investments
ShortTermInvestments
|
96198000 | |
CY2013Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3177000 | |
CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
117182000 | |
CY2013Q4 | rgls |
Short Term Investments Amortized Cost
ShortTermInvestmentsAmortizedCost
|
96181000 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.41 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.41 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
35933961 | shares | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-14587000 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3929209 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
35933961 | shares | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
268000 | ||
us-gaap |
Nonoperating Gains Losses
NonoperatingGainsLosses
|
-4458000 | ||
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-29000 | ||
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
1000 | ||
us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
19984000 | ||
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-14576000 | ||
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
105000 | ||
us-gaap |
Revenues
Revenues
|
7997000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
889000 | ||
us-gaap |
Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
|
56000 | ||
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-14606000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-10235000 | ||
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
96000 | ||
us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
135000 | ||
us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-1000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-14577000 | ||
us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-647000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
233000 | ||
us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-10000 | ||
us-gaap |
Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
|
1055000 | ||
us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-327000 | ||
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3628000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1546000 | ||
us-gaap |
Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
|
19000 | ||
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-21382000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-7028000 | ||
us-gaap |
Operating Expenses
OperatingExpenses
|
18232000 | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1000 | ||
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-7997000 | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
160000 | ||
us-gaap |
Interest Expense
InterestExpense
|
18000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
717000 | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
289000 | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
629000 | ||
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1546000 | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
14604000 | ||
us-gaap |
Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
|
13320000 | ||
us-gaap |
Other Significant Noncash Transaction Value Of Consideration Received1
OtherSignificantNoncashTransactionValueOfConsiderationReceived1
|
920000 | ||
dei |
Trading Symbol
TradingSymbol
|
RGLS | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
REGULUS THERAPEUTICS INC. | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Accelerated Filer | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-06-30 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001505512 | ||
us-gaap |
Fair Value Assumptions Weighted Average Volatility Rate
FairValueAssumptionsWeightedAverageVolatilityRate
|
0.80 | pure | |
us-gaap |
Fair Value Inputs Entity Credit Risk
FairValueInputsEntityCreditRisk
|
0.064 | pure | |
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.57 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
1115000 | shares | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.57 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
43028198 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
7.71 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-19051000 | ||
us-gaap |
Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
|
0.0024 | pure | |
us-gaap |
Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
|
1256232 | shares | |
us-gaap |
Revenues
Revenues
|
2367000 | ||
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
273000 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
4.89 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4044298 | shares | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt; TEXT-INDENT: 4%"> Our condensed financial statements are prepared in accordance with GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our financial statements and accompanying notes. Although these estimates are based on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ from these estimates and assumptions.</p> </div> | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
2.03 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
43028198 | shares | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
53000 | shares | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
731000 | ||
us-gaap |
Nonoperating Gains Losses
NonoperatingGainsLosses
|
-1171000 | ||
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-26000 | ||
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
1000 | ||
us-gaap |
Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
|
48301000 | ||
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-24713000 | ||
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
117000 | ||
us-gaap |
Unrealized Gain On Securities
UnrealizedGainOnSecurities
|
20000 | ||
us-gaap |
Interest Paid
InterestPaid
|
21000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1197000 | ||
us-gaap |
Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
|
70000 | ||
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-24740000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-23718000 | ||
us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
34000 | ||
us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
197000 | ||
us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
-18000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-24714000 | ||
us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-876000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
10214000 | ||
us-gaap |
Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
|
-124000 | ||
us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
-109000 | ||
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5686000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3083000 | ||
us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-7783000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
1054000 | ||
us-gaap |
Unrealized Loss On Securities
UnrealizedLossOnSecurities
|
29000 | ||
us-gaap |
Operating Expenses
OperatingExpenses
|
26085000 | ||
us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
5000000 | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1000 | ||
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-1896000 | ||
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
1412000 | ||
us-gaap |
Interest Expense
InterestExpense
|
21000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1729000 | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
9728000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
556000 | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
700000 | ||
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3083000 | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
20399000 | ||
us-gaap |
Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
|
50120000 | ||
CY2012Q4 | us-gaap |
Debt Instrument Maturity Date
DebtInstrumentMaturityDate
|
2015-10-09 | |
CY2013 | us-gaap |
Fair Value Assumptions Weighted Average Volatility Rate
FairValueAssumptionsWeightedAverageVolatilityRate
|
0.66 | pure |
CY2013 | us-gaap |
Fair Value Inputs Entity Credit Risk
FairValueInputsEntityCreditRisk
|
0.074 | pure |
CY2013 | us-gaap |
Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
|
0.00325 | pure |
CY2013 | us-gaap |
Unrealized Gain On Securities
UnrealizedGainOnSecurities
|
42000 | |
CY2013 | us-gaap |
Unrealized Loss On Securities
UnrealizedLossOnSecurities
|
25000 | |
CY2013Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.20 | |
CY2013Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.20 | |
CY2013Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
35994642 | shares |
CY2013Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4257789 | shares |
CY2013Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
35994642 | shares |
CY2013Q2 | us-gaap |
Nonoperating Gains Losses
NonoperatingGainsLosses
|
-2697000 | |
CY2013Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-44000 | |
CY2013Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-7338000 | |
CY2013Q2 | us-gaap |
Revenues
Revenues
|
4759000 | |
CY2013Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-7392000 | |
CY2013Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4686000 | |
CY2013Q2 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
63000 | |
CY2013Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-7348000 | |
CY2013Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1723000 | |
CY2013Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
9445000 | |
CY2013Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
10000 | |
CY2013Q2 | us-gaap |
Interest Expense
InterestExpense
|
18000 | |
CY2013Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
759000 | |
CY2013Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
7722000 | |
CY2014Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.28 | |
CY2014Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.29 | |
CY2014Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
44799536 | shares |
CY2014Q2 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
|
1437053 | shares |
CY2014Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
2052638 | shares |
CY2014Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
43362483 | shares |
CY2014Q2 | us-gaap |
Nonoperating Gains Losses
NonoperatingGainsLosses
|
953000 | |
CY2014Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
17000 | |
CY2014Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-11973000 | |
CY2014Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-12926000 | |
CY2014Q2 | us-gaap |
Revenues
Revenues
|
736000 | |
CY2014Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-11956000 | |
CY2014Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-13013000 | |
CY2014Q2 | us-gaap |
Interest And Other Income
InterestAndOtherIncome
|
97000 | |
CY2014Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11973000 | |
CY2014Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2954000 | |
CY2014Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
13749000 | |
CY2014Q2 | us-gaap |
Interest Expense
InterestExpense
|
10000 | |
CY2014Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1684000 | |
CY2014Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
10795000 |